INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
1
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.72M
14.6K sh
Jan 26, 2026
Page 1389 of 1786
← PrevNext →
Jan 28, 2026
traded Jan 26, 2026
+2d
SEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
7,875 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

59
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$1.56M
1,678 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

59
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$1.16M
1,242 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

59
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$2.46M
2,660 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

59
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$1.38M
1,494 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

56
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$431K
468 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

56
MS
Miller Charles S.Senior EVP-Sales
FASTFASTENAL CO
Open-market purchase
BUY$783
20 sh
Apr 7, 2025Jan 27, 2026
traded Apr 7, 2025
+295dSEC Form 4

Evidence

56
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$804K
875 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

54
MJ
Mettler JodyChief Operating Officer
BTGOBITGO HOLDINGS, INC.
Open-market sale
SELL$418K
25.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

53
HP
Horowitz Jeff PeterChief Compliance Officer
BTGOBITGO HOLDINGS, INC.
Open-market sale
SELL$1.94M
116.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$282K
302 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$468K
505 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$271K
295 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$402K
435 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
MS
Miller Charles S.Senior EVP-Sales
FASTFASTENAL CO
Open-market purchase
BUY$783
20 sh
Apr 14, 2025Jan 27, 2026
traded Apr 14, 2025
+288dSEC Form 4

Evidence

52
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$520K
560 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$250K
272 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$292K
316 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$256K
276 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$281K
306 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$373K
400 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$475K
512 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$270K
291 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

52
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$601K
653 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence